Abstract
© 2013 IEEE. Early detection of skin cancer, particularly melanoma, is crucial to enable advanced treatment. Due to the rapid growth in the number of skin cancers, there is a growing need of computerised analysis for skin lesions. The state-of-the-art public available datasets for skin lesions are often accompanied with a very limited amount of segmentation ground truth labeling. Also, the available segmentation datasets consist of noisy expert annotations reflecting the fact that precise annotations to represent the boundary of skin lesions are laborious and expensive. The lesion boundary segmentation is vital to locate the lesion accurately in dermoscopic images and lesion diagnosis of different skin lesion types. In this work, we propose the fully automated deep learning ensemble methods to achieve high sensitivity and high specificity in lesion boundary segmentation. We trained the ensemble methods based on Mask R-CNN and DeeplabV3+ methods on ISIC-2017 segmentation training set and evaluate the performance of the ensemble networks on ISIC-2017 testing set and PH2 dataset. Our results showed that the proposed ensemble methods segmented the skin lesions with Sensitivity of 89.93% and Specificity of 97.94% for the ISIC-2017 testing set. The proposed ensemble method Ensemble-A outperformed FrCN, FCNs, U-Net, and SegNet in Sensitivity by 4.4%, 8.8%, 22.7%, and 9.8% respectively. Furthermore, the proposed ensemble method Ensemble-S achieved a specificity score of 97.98% for clinically benign cases, 97.30% for the melanoma cases, and 98.58% for the seborrhoeic keratosis cases on ISIC-2017 testing set, exhibiting better performance than FrCN, FCNs, U-Net, and SegNet.
Highlights
Cancers of the skin are the most common form of malignancy in humans [1]
If there is no prediction from DeeplabV3+, the ensemble methods pick up the prediction of Mask R-Convolutional Neural Networks (CNN) and vice versa
SCOPE Robust end-to-end skin segmentation solutions are very important to provide inference according to the ABCD rule system for the lesion diagnosis of melanoma
Summary
Cancers of the skin are the most common form of malignancy in humans [1]. The most common malignant skin lesions are melanoma, squamous cell carcinoma and basal cell carcinoma. It is estimated that in 2019, 96,480 new cases will be diagnosed with melanoma and more than 7,000 people will die from the disease in the United States [2], [3]. Skin cancer specialists examine their patients’ skin lesions using visual inspection aided by hand-held dermoscopy. They may capture digital close-up (macroscopic) and dermoscopic (microscopic) images. Dermoscopy is a means to examine the skin using a bright light and magnification, and employs either polarisation or immersion fluid
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.